We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 22, 2020

Lopinavir–Ritonavir in Patients Admitted to the Hospital With COVID-19

The Lancet


Additional Info

The Lancet
Lopinavir–Ritonavir in Patients Admitted to Hospital With COVID-19 (RECOVERY): A Randomised, Controlled, Open-Label, Platform Trial
Lancet 2020 Oct 05;[EPub Ahead of Print], RECOVERY Collaborative Group

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading